Related Experiment Videos
Myocardial disease in hypertensive-diabetic patients
1Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70122.
Insights
Diabetic cardiomyopathy is a distinct heart condition linked to diabetes, separate from coronary artery disease. Combining diabetes with hypertension worsens heart function, necessitating targeted antihypertensive treatments.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus is associated with a unique cardiomyopathy, independent of coronary atherosclerosis.
- This diabetic cardiomyopathy presents with specific clinical, physiological, and biochemical abnormalities.
- Hyperglycemia and hyperlipidemia are implicated as potential mechanisms in its development.
Purpose of the Study:
- To explore the characteristics and mechanisms of diabetic cardiomyopathy.
- To investigate the synergistic impact of co-existing hypertension and diabetes on cardiac function.
- To identify optimal antihypertensive treatment strategies for patients with diabetes.
Main Methods:
- Review of experimental and clinical evidence on diabetic cardiomyopathy.
- Analysis of the interplay between diabetes, hypertension, and myocardial abnormalities.
- Evaluation of antihypertensive drug profiles for efficacy and safety in diabetic patients.
Main Results:
- Diabetic cardiomyopathy is a distinct entity with unique pathophysiological features.
- The combination of hypertension and diabetes exacerbates cardiomyopathy more severely than either condition alone.
- Certain antihypertensive agents, like calcium antagonists and ACE inhibitors, show promise for treating hypertensive diabetic patients.
Conclusions:
- Diabetic cardiomyopathy is a significant clinical concern.
- Co-morbid hypertension in diabetic patients leads to a more severe cardiac phenotype.
- Antihypertensive therapy in diabetics requires careful selection to avoid adverse effects on cardiac function and metabolic control.
Abstract:
Experimental and clinical evidence points to the existence of a cardiomyopathy associated with diabetes mellitus that is not due to coronary atherosclerosis. The condition is characterized by distinct clinical presentations and physiologic and biochemical abnormalities. Potential mechanisms for the development of diabetic cardiomyopathy are complex but are probably associated, in part, with hyperglycemia and hyperlipidemia. Primary hypertension is also associated with the development of myocardial abnormalities. Many of these changes are similar to those seen in diabetic cardiomyopathy. It is now clear that the co-existence of hypertension and diabetes mellitus produces a more severe cardiomyopathy than that produced by hypertension or diabetes alone. Potential mechanisms for interaction are numerous. Treatment of hypertension in diabetic patients must be targeted to more specific needs. Antihypertensive drugs should not worsen cardiac risk factors or glucose control and should have favorable effects on left ventricular function. The calcium antagonists and angiotensin-converting enzyme inhibitors have pharmacologic profiles that make them attractive as monotherapy for diabetic patients.